News
-
-
PRESS RELEASE
Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals
Marinomed Biotech AG successfully completes the sale of Carragelose business to Unither Pharmaceuticals, marking a strategic decision. Deal includes upfront payment of EUR 5 million and transition service agreement -
-
-
-
-
-
-
-
REGULATED PRESS RELEASE
EURAZEO TO INVEST IN MAPAL, A LEADING PAN-EUROPEAN HOSPITALITY SOFTWARE PROVIDER, ACQUIRING A MAJORITY STAKE FROM PSG EQUITY
Eurazeo to invest in Mapal, a leading Pan-European hospitality software provider, acquiring a majority stake from PSG Equity. Transaction subject to regulatory approvals. Mapal focuses on AI-powered SaaS platforms for the hospitality sector
